Health & Vet Care
Vet clinic economics, animal drugs and approvals, diagnostics and longevity, pet insurance and health claims. How pet care runs as a business, and who makes money from it.




Start here
- Why Vet Clinics Don't Post Prices, and Who Is Changing That
Only 3 of 157 clinic websites post a price. Why opacity pays, how insurance locks owners in, and who now competes on posted prices.
- Dog Longevity Research Is Booming. Pet Brands Are Selling Supplements Instead.
Four datasets on where the science, the FDA and the brand filings are heading in dog health and aging.
- BPC-157 for Dogs: Peptides, Bad Vials and the FDA Gap
Owners inject peptides dosed on Reddit. What the FDA vote covers, what it does not, and the canine trial nobody has run.
- Fear Free at 10: How Low-Stress Handling Became Pet Care Infrastructure
How one vet credential grew into nine programs, and what its injury and booking data does and does not show.
Key numbers
- 1.9%
of vet clinic websites post any service price. Only 3 of 157 small-animal clinics across eight states did, in a category worth an estimated $41B a year.
- 53.9%
rise in US veterinary service prices from December 2019 to October 2026, against 31.3% for all items. Price is now doing the work that falling visit counts no longer do.
- 8 of 26
original FDA dog drug approvals since 2021 came through conditional approval, about 31%. A 2018 law opened that fast lane to dogs and cats.
- ~30%
of consumer-submitted peptide vials tested by an independent lab came back mislabeled, off-dose or contaminated. No canine trial of BPC-157 exists.
Sources: Frontiers in Veterinary Science (2026), APPA, BLS consumer price index, NBC Washington reporting on independent vial testing (July 2026), and The Underbite analysis of the FDA animal drug database. Full sourcing is in each linked article.





